Best of LinkedIn: Health Tech CW 48/ 49

Show notes

We curate most relevant posts about Health Tech on LinkedIn and regularly share key takeaways.

This edition details a massive, ongoing transformation in healthcare driven by advanced technologies, particularly artificial intelligence (AI) and robotics. AI applications are widespread, enhancing everything from personalized cancer radiotherapy and accelerating drug discovery to providing proactive, precision diagnostics in fields like cardiology and radiology, where new tools like deep-learning reconstruction are becoming standard. Significant developments in surgical technology include the FDA clearance of Medtronic’s Hugo robotic system and innovations aimed at making minimally invasive procedures modular and globally accessible, while smaller robots promise non-surgical treatments for conditions like kidney stones. Furthermore, a strong emphasis is placed on the ethical and strategic implementation of these tools, stressing the critical need for physician and stakeholder engagement in AI strategy to ensure adoption and address the digital divide and issues of global equity. Legislative efforts, such as the Health Tech Investment Act, are being introduced to ensure reliable Medicare payment for these technologies, advancing patient access. Finally, infrastructure advancements, such as the introduction of helium-free 3.0T MRI platforms and regional health information systems, are highlighted as crucial steps for building resilient, high-quality, and more connected healthcare systems.

This podcast was created via Google NotebookLM.

Show transcript

00:00:00: This episode is provided by Thomas Allgeier and Frannis, based on the most relevant LinkedIn posts on health tech in CW-Forty-Eight and Forty-Nine.

00:00:09: Frannis equips product and strategy teams with market and competitive intelligence to navigate the health tech landscape.

00:00:15: Welcome back.

00:00:16: Today we are doing a deep dive into the health tech landscape, looking at the key strategic moves and the big breakthroughs from the last couple of weeks of LinkedIn posts.

00:00:25: And the signal we're picking up is, well, it's pretty clear.

00:00:29: It is.

00:00:30: The industry is past the point of just casual experimentation.

00:00:33: Right.

00:00:33: It's not about pilots anymore.

00:00:35: Exactly.

00:00:35: I mean, if you had to boil it all down, the real story is this shift from pilots to actual operational rollout.

00:00:42: The focus isn't just on what a technology can do in a lab.

00:00:45: It's about how it works in the real

00:00:46: world.

00:00:47: Yeah.

00:00:47: How it integrates into a clinical workflow, how it connects to the data, and maybe most importantly, how you get paid for it.

00:00:52: It has to be payment ready.

00:00:54: So that financial and clinical loop is finally tightening.

00:00:57: Tech is being judged on its ability to scale, not just its novelty.

00:01:01: Precisely.

00:01:02: And to make sense of all this, we've grouped the insights into four main clusters.

00:01:07: First, how AI strategy is maturing.

00:01:10: Second, the massive shifts in diagnostics and imaging, especially with everything coming out of the RSNA conference.

00:01:16: Okay.

00:01:16: Third is the expansion of robotic surgery.

00:01:19: And finally, the big strategic moves in digital care delivery and, you know, the whole ecosystem that ties it all together.

00:01:26: Okay, let's unpack this.

00:01:27: And I think we have to start with the biggest driver of change, right?

00:01:31: Artificial intelligence.

00:01:32: We've talked about pilots for years, but what does this new strategic phase actually look like?

00:01:38: It looks like architecture.

00:01:40: I mean, Bill Russell made a great point that too many health systems have something like forty AI tools and no architecture.

00:01:45: That's not a strategy.

00:01:47: That's just a shopping

00:01:47: habit.

00:01:48: It's a shopping habit that creates a ton of integration debt.

00:01:51: He says the new leaders are becoming Renaissance architects.

00:01:54: Renaissance

00:01:55: architect.

00:01:55: I like that.

00:01:56: But what does it really mean?

00:01:57: Is that just a fancy new name for a CIO?

00:01:59: Well,

00:01:59: not quite.

00:02:00: The Renaissance part implies a total rethink of the foundation.

00:02:05: A CIO manages IT.

00:02:07: A Renaissance architect is building the blueprint for clinical transformation.

00:02:12: They're not just buying another point solution.

00:02:14: They're designing the whole system from the ground up to connect all the data and anticipate how the workflow is going to change.

00:02:21: Exactly.

00:02:22: and to prepare for those complex reimbursement pathways we just mentioned.

00:02:26: That makes perfect sense because without that architecture you lose all the efficiencies everyone is so excited about.

00:02:32: Sameer Saleem pointed out that professionals are, you know, thrilled about AI enhancing outcomes and reducing costs.

00:02:37: But excitement doesn't fix a broken operational structure.

00:02:40: No, it doesn't.

00:02:42: And that structure, it absolutely has to be clinician led.

00:02:46: Christa Calpe highlighted the AMA's launch of the Center for Digital Health and AI.

00:02:51: It's a bit of a defensive move, but it's necessary.

00:02:53: To make sure physicians are shaping the policy up front, not just dealing with the messy aftermath of a new tool.

00:02:59: Right.

00:02:59: You need it to fit the workflow seamlessly from day one.

00:03:02: And a huge signal of market maturity is when the regulators finally step up.

00:03:07: We saw that in the U.S.

00:03:08: with the proposed Health Tech Investment Act, which Christian Usman and John Cole mentioned.

00:03:14: It's designed to improve Medicare reimbursement for validated AI software.

00:03:18: Payment friction is the ultimate killer of scale.

00:03:21: So tackling that unlocks everything.

00:03:24: And while the U.S.

00:03:24: system is playing catch up on payment, consumers are already way ahead.

00:03:28: A survey in Germany from Privgo's Dr.

00:03:31: Michael Quinton showed that twenty-five percent of citizens are already using AI tools.

00:03:36: Twenty-five percent?

00:03:37: Wow.

00:03:37: Yeah.

00:03:38: Things like symptom checkers for health questions.

00:03:40: That's a huge uptake.

00:03:41: Which puts immediate pressure on ethics and governance, I'd imagine.

00:03:44: It does.

00:03:45: And a systematic review from Jan Beger found a really critical gap here.

00:03:49: Hospital-based AI research talks a lot about ethics, but it almost never operationalizes those principles.

00:03:55: What do you mean by that?

00:03:56: Well, most worryingly, only six percent of the studies he looked at even addressed sustainability or the environmental costs of training these huge models.

00:04:03: Wow, so they're completely ignoring the data's carbon footprint.

00:04:06: Exactly.

00:04:07: And when you ignore these things, you get resistance.

00:04:10: Sigrid Bergen and Assim Khan really reinforced this.

00:04:13: They said AI strategy fails without early, inclusive co-creation.

00:04:18: So bring everyone to the table from day one.

00:04:21: Or else clinicians show a fight-or-flight response.

00:04:24: which leads to the low adoption we see all the time.

00:04:27: And while hospitals are sorting out governance, Big Pharma is just sprinting ahead on R&D.

00:04:32: Wolfgang Schleifer highlighted NVIDIA's partnerships with companies like Eli Lilly.

00:04:37: Oh yeah, they're building a full-on AI factory to train models.

00:04:40: It's not just a tool for them anymore.

00:04:41: It's a complete transformation of their R&D pipeline to, you know, drastically cut drug discovery timelines.

00:04:48: Let's pivot now to that second cluster, diagnostics, imaging, and radiology.

00:04:53: The recent RSNA conference proved that imaging is probably the fastest runway for scalable AI adoption right now.

00:05:00: And it's not just about image quality, is it?

00:05:01: It's about resilience.

00:05:02: Resilience,

00:05:03: yes.

00:05:04: And that starts with solving a massive geopolitical and supply chain headache.

00:05:08: Healing.

00:05:08: Healing.

00:05:09: Rakesh Kumar and others, we're all talking about Phillips unveiling of the three Tesla Blue Seal MRI.

00:05:15: It's a near zero helium system.

00:05:17: Near zero.

00:05:17: Okay.

00:05:18: Why is that specific detail such a huge breakthrough?

00:05:21: because a typical MRI scanner needs about fifteen hundred liters of liquid helium to stay cool.

00:05:28: And helium is scarce, it's non-renewable, and the supply chain is incredibly volatile.

00:05:33: So if your helium runs out, your multi-million dollar scanner is basically a paperweight for weeks.

00:05:38: Or months, yeah.

00:05:39: Removing that dependence just fundamentally changes the entire operational life cycle for an MRI system.

00:05:45: It means more uptime, lower cost, and one less massive headache for the hospital.

00:05:49: That's a fantastic example of hardware and material science solving a core operational problem.

00:05:54: And beyond the hardware, AI is improving the images themselves.

00:05:58: Precisely.

00:05:59: Killian Salty noted how deep learning reconstruction, specifically ARREC and DL, is dramatically improving the quality of arterial pancreas MRIs.

00:06:07: You get sharper images, better lesion detection.

00:06:09: All

00:06:10: while keeping the patient's breath hold really short.

00:06:12: Around twenty-two seconds.

00:06:13: Okay.

00:06:13: Which is great for patient throughput and of course clinical confidence.

00:06:16: So if AI is handling more of the processing and analysis, the radiologist's role has to be changing pretty profoundly.

00:06:23: It is.

00:06:23: Matthias Goyen put it very clearly.

00:06:25: The future is human-led collaboration with AI.

00:06:29: Radiologists are shifting from just being image readers to becoming orchestrators.

00:06:33: Turning all that data into actual wisdom.

00:06:35: Exactly.

00:06:36: And you see that backed up by tools like GE Healthcare's Imaging Three Sixty, which Simon Philip Ross detailed.

00:06:43: It uses AI to automate analysis and optimize things like scheduling and device use.

00:06:47: And here's where it gets really interesting.

00:06:49: Connecting this back to that macro trend of longevity and early detection, especially in cardiology.

00:06:54: Right.

00:06:54: Longevity demands you shift the diagnostic timeline way earlier.

00:06:59: Kirk Sanford detailed a non-invasive tool called CADScore.

00:07:02: It uses acoustic AI to listen for subtle turbulence in blood flow.

00:07:06: To detect plaque buildup without any radiation.

00:07:09: And it delivers over ninety-six percent diagnostic certainty.

00:07:12: That kind of certainty from a non-invasive tool is a profound game changer for preventative medicine.

00:07:18: And the validation is accelerating.

00:07:21: Campbell Rogers confirmed that heart flow plaque analysis is now the most clinically validated framework for CAD risk stratification.

00:07:28: Dr.

00:07:29: Emery Urturk even predicted that by twenty thirty, AI-enhanced multimodal imaging combining ECHO, CMR, and CT will probably be the new diagnostic standard.

00:07:38: It's all about that AI-driven convergence.

00:07:41: Let's move into the operating theater now.

00:07:43: And that third cluster of robotic surgery and interventional tech.

00:07:46: If we can see better with AI, the goal is now to make the intervention less invasive and crucially more accessible.

00:07:53: That accessibility part is key, isn't it?

00:07:55: It is.

00:07:56: Ilani Dalinon highlighted CMR surgicals versus system.

00:07:59: It's modular, it's miniaturized, a truly digital native robot.

00:08:04: The whole design is about lowering the typical barriers to entry for minimally invasive surgery.

00:08:08: Like the huge cost.

00:08:10: the space it takes up and the steep learning curve of older systems.

00:08:13: Exactly.

00:08:14: This is what helps push adoption globally.

00:08:16: Meanwhile, the big established players are expanding into new clinical areas.

00:08:19: Medtronic's Hugo-RES system is a perfect example.

00:08:23: It just got FDA clearance for urologic procedures, showing real precision and prostatectomy.

00:08:29: Bob Reddy and Dr.

00:08:30: James Porter emphasized that its modular arms improve flexibility and ergonomics for the surgeon.

00:08:36: And they can operate from an open workstation, which improves communication with the whole team.

00:08:40: A

00:08:41: huge deal for human factors in the OR.

00:08:43: And we're seeing robotics move outside the operating room entirely.

00:08:47: Petra Teglis shared news about a rice-sized, magnetically guided robot.

00:08:51: Tiny

00:08:52: little

00:08:52: bot.

00:08:53: Designed to break apart kidney stones without surgery.

00:08:56: It really points to a future of safer, less invasive, interventional platforms.

00:09:00: And speaking of blurring boundaries, Austin Chiang called up the artificial boundary between surgery and endoscopy.

00:09:07: He's advocating for more collaboration.

00:09:10: Because the turf war is just slowdown innovation and hurt patients.

00:09:14: He argues patients benefit most from convergence, like with endoluminal robotics.

00:09:19: But the medical training models just haven't kept up.

00:09:21: It

00:09:21: seems like a solvable problem, though.

00:09:23: It is.

00:09:24: Dr.

00:09:24: Quinlan D. Buchlak noted a similar kind of strategic complexity with TVI.

00:09:29: Post-TVI coronary access is becoming a critical issue.

00:09:32: Okay, hold on.

00:09:32: For those who don't follow cardiology that closely, can you quickly break down what TVI is and why access afterwards is a problem?

00:09:40: Sure.

00:09:40: TVI is transcatheter aortic valve implantation, a minimally invasive way to replace the aortic valve.

00:09:47: The issue Dr.

00:09:48: Booklack raised is that as the tech gets better, it's being used in younger, healthier patients.

00:09:53: So they'll live longer and need more procedures down the road.

00:09:55: Exactly.

00:09:56: If you get a Pavi-i in your sixties, you'll likely need future coronary work.

00:10:00: But that TBI valve can make it surgically much harder to access the coronary arteries later on.

00:10:05: It's a huge, long-term strategic consideration.

00:10:08: Integration complexity in action.

00:10:10: Okay, let's hit our final cluster.

00:10:12: digital care delivery strategy and the ecosystem because all these breakthroughs need a way to scale and that means solving access and delivery.

00:10:20: Absolutely.

00:10:21: Sima Verma talking about Oracle's commitment detailed a plan to use AI and even lower earth orbit satellites to revolutionize rural health care in the US.

00:10:29: A direct technological response to provider shortages and hospital closures.

00:10:34: But scaling digital health also requires excellence in the back office.

00:10:38: It's not all about the clinical evidence.

00:10:41: Josefa Dahud showed this perfectly with PhysiTrack, a digital rehab platform.

00:10:46: They used NetSuite to manage their finances across five different countries.

00:10:50: Right.

00:10:51: It proves that streamlined operations and automation are just as vital to success as the core technology itself.

00:10:57: That efficiency is what enables those big reimbursement milestones, too.

00:11:01: Martin Kirchberger shared some great news from Switzerland.

00:11:04: A

00:11:04: huge policy step.

00:11:05: Yeah, their health authorities have cleared the way for mandatory insurance reimbursement for digital health apps, they call them DGA, for cognitive behavioral therapy, starting in July, twenty twenty six.

00:11:16: That's the key to unlocking scale for digital therapeutics in Europe.

00:11:20: But that scale requires data to flow freely.

00:11:23: We're seeing progress with things like the Lumio RHIS and the Azores Digital Health Project, which Thomas Shabetzberger highlighted.

00:11:29: Building

00:11:30: those bridges for deity exchange between organizations.

00:11:33: But even with a great EMR, you still hear about end user burnout.

00:11:37: All the time.

00:11:37: Vivek Arora explained why.

00:11:40: EMR success depends on collaboration between four teams.

00:11:43: Implementation, application management, infrastructure, and client operations.

00:11:48: If they don't work together, the end users, the doctors, and nurses feel unsupported.

00:11:53: It's an operational failure, not a tech failure.

00:11:55: And finally, there's a profound moral and financial case to be made here.

00:12:00: Lisa Gurry brought up the urgent need for genomic newborn screening.

00:12:04: This really ties it all together.

00:12:06: We have the science right now to diagnose rare diseases at birth instead of making families wait five years for symptoms to show up.

00:12:13: And the cost of not doing it is staggering and estimated one trillion dollars a year in the U.S.

00:12:19: alone.

00:12:20: A trillion dollars.

00:12:21: It makes early data driven intervention not just a moral obligation but a clear financial imperative.

00:12:27: So when you synthesize all this AI driving strategy, resilient imaging, solving real-world problems, robotics getting more accessible, and digital platforms focusing on operational efficiency, the big picture is one of deep integration.

00:12:39: It's moving beyond just isolated devices.

00:12:41: Exactly.

00:12:42: We're seeing massive collaborations like Mayo Clinic and GE Healthcare, and new workflow.

00:12:47: AI startups, as Blake Tindall noted, are acting as the glue to connect devices, diagnostics, and care.

00:12:53: And

00:12:54: that structural shift is driving the big macro trend, Mark Sluigas pointed out, the transition from disease care to well care.

00:13:00: This shift, with an estimated eight hundred and fifty billion dollar annual market, means everyone has to start integrating prevention and longevity into their core strategy.

00:13:08: Indeed.

00:13:09: If all these technologies are successful, the whole industry's purpose changes from just reacting to sickness to proactively maximizing well-being.

00:13:17: Which brings us to our final provocative thought for you to consider.

00:13:21: If the future of health tech is truly pivoting toward maximizing wellness and optimizing prevention, what does your product roadmap look like?

00:13:29: Is data-driven prevention baked in from the start, or is it still just an afterthought?

00:13:34: If you enjoyed this deep dive, new episodes drop every two weeks.

00:13:37: Also, check out our other editions on ICT and tech insights, defense tech, cloud, digital products and services, artificial intelligence, and sustainability, and green ICT.

00:13:46: Thank you for joining us for this analysis of the HealthTech landscape and make sure you subscribe so you don't miss the next one.

New comment

Your name or nickname, will be shown publicly
At least 10 characters long
By submitting your comment you agree that the content of the field "Name or nickname" will be stored and shown publicly next to your comment. Using your real name is optional.